ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC12599-10mM (in 1mL DMSO) |
|
150812-13-8 |
Retigabine dihydrochloride
|
0 | C16H20Cl2FN3O2 | |
GC12599-100mg |
|
150812-13-8 |
Retigabine dihydrochloride
|
0 | C16H20Cl2FN3O2 | |
GC12599-50mg |
|
150812-13-8 |
Retigabine dihydrochloride
|
0 | C16H20Cl2FN3O2 | |
GC12599-10mg |
|
150812-13-8 |
Retigabine dihydrochloride
|
0 | C16H20Cl2FN3O2 | |
GC12599-5mg |
|
150812-13-8 |
Retigabine dihydrochloride
|
0 | C16H20Cl2FN3O2 | |
GC12598-1mg |
|
229961-45-9 |
AGN 194310
|
0 | C28H24O2S | |
GC12597-50mg |
|
348575-88-2 |
Optovin
|
0 | C15H13N3OS2 | |
GC12597-10mg |
|
348575-88-2 |
Optovin
|
0 | C15H13N3OS2 | |
GC12596-10mM (in 1mL DMSO) |
|
170151-24-3 |
Nepicastat (SYN-117) HCl
|
0 | C14H15F2N3S.HCl | |
GC12596-50mg |
|
170151-24-3 |
Nepicastat (SYN-117) HCl
|
0 | C14H15F2N3S.HCl | |
GC12596-5mg |
|
170151-24-3 |
Nepicastat (SYN-117) HCl
|
0 | C14H15F2N3S.HCl | |
GC12596-10mg |
|
170151-24-3 |
Nepicastat (SYN-117) HCl
|
0 | C14H15F2N3S.HCl | |
GC12595-500mg |
|
96020-91-6 |
DL-α-Difluoromethylornithine (hydrochloride hydrate)
|
0 | C6H12F2N2O2 • HCl [H2O] | |
GC12595-100mg |
|
96020-91-6 |
DL-α-Difluoromethylornithine (hydrochloride hydrate)
|
0 | C6H12F2N2O2 • HCl [H2O] | |
GC12595-50mg |
|
96020-91-6 |
DL-α-Difluoromethylornithine (hydrochloride hydrate)
|
0 | C6H12F2N2O2 • HCl [H2O] | |
GC12594-25mg |
|
— |
TAMRA azide, 5- isomer
|
0 | C28H28N6O4 | |
GC12594-5mg |
|
— |
TAMRA azide, 5- isomer
|
0 | C28H28N6O4 | |
GC12593-50mg |
|
951322-11-5 |
Desformylflustrabromine hydrochloride
|
0 | C16H21BrN2.HCl | |
GC12593-10mg |
|
951322-11-5 |
Desformylflustrabromine hydrochloride
|
0 | C16H21BrN2.HCl | |
GC12592-10mM (in 1mL DMSO) |
|
70458-95-6 |
Pefloxacin Mesylate
|
0 | C18H24FN3O6S | |